1. Home
  2. BLCO vs BGC Comparison

BLCO vs BGC Comparison

Compare BLCO & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$19.53

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Logo BGC Group Inc.

BGC

BGC Group Inc.

N/A

Current Price

$11.03

Market Cap

5.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BLCO
BGC
Founded
1853
1945
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
5.2B
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
BLCO
BGC
Price
$19.53
$11.03
Analyst Decision
Buy
Buy
Analyst Count
15
2
Target Price
★ $21.93
$16.00
AVG Volume (30 Days)
980.7K
★ 2.6M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
★ 0.72%
EPS Growth
N/A
★ 24.00
EPS
N/A
★ 0.46
Revenue
★ $5,101,000,000.00
$2,941,460,000.00
Revenue This Year
$7.83
$23.77
Revenue Next Year
$5.90
$5.59
P/E Ratio
★ N/A
$24.24
Revenue Growth
6.47
★ 29.99
52 Week Low
$14.65
$8.42
52 Week High
$21.40
$12.89

Technical Indicators

Market Signals
Indicator
BLCO
BGC
Relative Strength Index (RSI) 47.83 43.91
Support Level $15.30 $10.29
Resistance Level $21.38 $11.89
Average True Range (ATR) 0.59 0.38
MACD -0.16 0.02
Stochastic Oscillator 2.76 44.78

Price Performance

Historical Comparison
BLCO
BGC

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, the Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Share on Social Networks: